The development of end-point assays to assess the safety and efficacy of intra-pulmonary gene therapy in cystic fibrosis

Bibliographic Details
Main Author:	Davies, Michael Gordon
Published:	Imperial College London 2009
Subjects:	616.2
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.520985

id	ndltd-bl.uk-oai-ethos.bl.uk-520985
record_format	oai_dc
spelling	ndltd-bl.uk-oai-ethos.bl.uk-5209852015-03-20T06:21:17ZThe development of end-point assays to assess the safety and efficacy of intra-pulmonary gene therapy in cystic fibrosisDavies, Michael Gordon2009616.2Imperial College Londonhttp://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.520985Electronic Thesis or Dissertation
collection	NDLTD
sources	NDLTD
topic	616.2
spellingShingle	616.2 Davies, Michael Gordon The development of end-point assays to assess the safety and efficacy of intra-pulmonary gene therapy in cystic fibrosis
author	Davies, Michael Gordon
author_facet	Davies, Michael Gordon
author_sort	Davies, Michael Gordon
title	The development of end-point assays to assess the safety and efficacy of intra-pulmonary gene therapy in cystic fibrosis
title_short	The development of end-point assays to assess the safety and efficacy of intra-pulmonary gene therapy in cystic fibrosis
title_full	The development of end-point assays to assess the safety and efficacy of intra-pulmonary gene therapy in cystic fibrosis
title_fullStr	The development of end-point assays to assess the safety and efficacy of intra-pulmonary gene therapy in cystic fibrosis
title_full_unstemmed	The development of end-point assays to assess the safety and efficacy of intra-pulmonary gene therapy in cystic fibrosis
title_sort	development of end-point assays to assess the safety and efficacy of intra-pulmonary gene therapy in cystic fibrosis
publisher	Imperial College London
publishDate	2009
url	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.520985
work_keys_str_mv	AT daviesmichaelgordon thedevelopmentofendpointassaystoassessthesafetyandefficacyofintrapulmonarygenetherapyincysticfibrosis AT daviesmichaelgordon developmentofendpointassaystoassessthesafetyandefficacyofintrapulmonarygenetherapyincysticfibrosis
_version_	1716797130454073344

The development of end-point assays to assess the safety and efficacy of intra-pulmonary gene therapy in cystic fibrosis

Similar Items